Hr Techx Corp.

Hr Techx Corp. company information, Employees & Contact Information

Explore related pages

Related company profiles:

HRTX, Corp. incorporates a technology-based approach to address and supports the transformation of companies to adapt to an agile culture. Its scope of service covers recruitment, employee engagement and retention, employee recognition and reward system, employee pay and bonuses, staff development and training, workforce relations, performance improvement, and benefits administration.

Company Details

Employees
26
Founded
-
Address
Three Central Makati, Makati,1227,philippines
Industry
Technology, Information And Internet
HQ
Makati
Looking for a particular Hr Techx Corp. employee's phone or email?

Hr Techx Corp. Questions

News

Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Yahoo Finance

New Analyst Forecast: $HRTX Given $3.0 Price Target | HRTX Stock News - Quiver Quantitative

New Analyst Forecast: $HRTX Given $3.0 Price Target | HRTX Stock News Quiver Quantitative

Rubric capital buys Heron Therapeutics (HRTX) shares worth $3.5m - Investing.com

Rubric capital buys Heron Therapeutics (HRTX) shares worth $3.5m Investing.com

When Will Heron Therapeutics, Inc. (NASDAQ:HRTX) Breakeven? - simplywall.st

When Will Heron Therapeutics, Inc. (NASDAQ:HRTX) Breakeven? simplywall.st

Heron Therapeutics Accelerates Q2 2025 Earnings Release: New Date and Key Details Revealed - Stock Titan

Heron Therapeutics Accelerates Q2 2025 Earnings Release: New Date and Key Details Revealed Stock Titan

Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates - Nasdaq

Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates Nasdaq

Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates Yahoo Finance

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina - PR Newswire

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina PR Newswire

Insider Purchase: Director at $HRTX Buys 1,766,546 Shares - Quiver Quantitative

Insider Purchase: Director at $HRTX Buys 1,766,546 Shares Quiver Quantitative

Biotech Leader Heron Therapeutics Sets Q2 Earnings Call: Key Financial Results Coming August 11 - Stock Titan

Biotech Leader Heron Therapeutics Sets Q2 Earnings Call: Key Financial Results Coming August 11 Stock Titan

Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics - Nasdaq

Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics Nasdaq

Lacklustre Performance Is Driving Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 26% Price Drop - simplywall.st

Lacklustre Performance Is Driving Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 26% Price Drop simplywall.st

With 60% institutional ownership, Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst the big guns - Yahoo Finance

With 60% institutional ownership, Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst the big guns Yahoo Finance

Wednesday 8/13 Insider Buying Report: WBD, HRTX - Nasdaq

Wednesday 8/13 Insider Buying Report: WBD, HRTX Nasdaq

Heron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value - PR Newswire

Heron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value PR Newswire

Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance

Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Yahoo Finance

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates - PR Newswire

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates PR Newswire

Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term - Yahoo Finance

Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term Yahoo Finance

Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5? - Yahoo Finance

Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5? Yahoo Finance

Heron Therapeutics Inc (HRTX) Quarterly 10-Q Report - qz.com

Heron Therapeutics Inc (HRTX) Quarterly 10-Q Report qz.com

$1.37 Billion Tax Asset Protection: Heron Therapeutics Adopts Strategic Rights Plan to Preserve NOLs - Stock Titan

$1.37 Billion Tax Asset Protection: Heron Therapeutics Adopts Strategic Rights Plan to Preserve NOLs Stock Titan

Heron Therapeutics: Middling Performance From Approved Therapies With No Pipeline - Seeking Alpha

Heron Therapeutics: Middling Performance From Approved Therapies With No Pipeline Seeking Alpha

Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company - Yahoo Finance

Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company Yahoo Finance

U.S. District Court Upholds Validity of CINVANTI® Patents - PR Newswire

U.S. District Court Upholds Validity of CINVANTI® Patents PR Newswire

Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") - PR Newswire

Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire

Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025 (NASDAQ:HRTX) - Seeking Alpha

Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025 (NASDAQ:HRTX) Seeking Alpha

Cyndeo Wealth Partners LLC Takes Position in Heron Therapeutics, Inc. $HRTX - MarketBeat

Cyndeo Wealth Partners LLC Takes Position in Heron Therapeutics, Inc. $HRTX MarketBeat

Heron Therapeutics: Four Horse Race Of Approved Therapies (NASDAQ:HRTX) - Seeking Alpha

Heron Therapeutics: Four Horse Race Of Approved Therapies (NASDAQ:HRTX) Seeking Alpha

Heron Therapeutics Strengthens Leadership: Former Veloxis CEO Takes COO Role with Major Stock Package - Stock Titan

Heron Therapeutics Strengthens Leadership: Former Veloxis CEO Takes COO Role with Major Stock Package Stock Titan

Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations - PR Newswire

Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations PR Newswire

Heron Therapeutics, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st

Heron Therapeutics, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates simplywall.st

Heron Therapeutics: Approved Therapy With Blockbuster Potential But Meager Revenues (NASDAQ:HRTX) - Seeking Alpha

Heron Therapeutics: Approved Therapy With Blockbuster Potential But Meager Revenues (NASDAQ:HRTX) Seeking Alpha

Risk Report: Can HRTX stock sustain revenue growth - July 2025 Review & Safe Swing Trade Setup Alerts - Trung tâm Dự báo KTTV quốc gia

Risk Report: Can HRTX stock sustain revenue growth - July 2025 Review & Safe Swing Trade Setup Alerts Trung tâm Dự báo KTTV quốc gia

symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast CNN

Heron Therapeutics: Zynrelef Developments Are Unlikely To Provide Relief To Investors - Seeking Alpha

Heron Therapeutics: Zynrelef Developments Are Unlikely To Provide Relief To Investors Seeking Alpha

Can HRTX stock sustain institutional interest - Portfolio Growth Summary & Weekly Watchlist of Top Performers - Trung tâm Dự báo KTTV quốc gia

Can HRTX stock sustain institutional interest - Portfolio Growth Summary & Weekly Watchlist of Top Performers Trung tâm Dự báo KTTV quốc gia

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain - PR Newswire

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain PR Newswire

Can HRTX stock sustain revenue growth - 2025 Market Overview & Growth Oriented Trading Recommendations - Trung tâm Dự báo KTTV quốc gia

Can HRTX stock sustain revenue growth - 2025 Market Overview & Growth Oriented Trading Recommendations Trung tâm Dự báo KTTV quốc gia

What drives HRTX stock price - Consistently superior profits - Jammu Links News

What drives HRTX stock price - Consistently superior profits Jammu Links News

HRTX - Heron Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

HRTX - Heron Therapeutics Inc Latest Stock News & Market Updates Stock Titan

HRTX News Today | Why did Heron Therapeutics stock go down today? - MarketBeat

HRTX News Today | Why did Heron Therapeutics stock go down today? MarketBeat

HRTX Stock Price and Chart — NASDAQ:HRTX - TradingView

HRTX Stock Price and Chart — NASDAQ:HRTX TradingView

Heron Therapeutics - HRTX - Stock Price Today - Zacks Investment Research

Heron Therapeutics - HRTX - Stock Price Today Zacks Investment Research

Heron Therapeutics (HRTX) Stock Price, News & Analysis - MarketBeat

Heron Therapeutics (HRTX) Stock Price, News & Analysis MarketBeat

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant